Parkinson's disease
Showing 9976 - 10000 of >10,000
COPD Trial in Germany, United Kingdom (QAW039, Placebo)
Terminated
- Chronic Obstructive Pulmonary Disease
- QAW039
- Placebo
-
Frankfurt, Germany
- +3 more
Oct 7, 2021
COVID-19, Corona Virus Infection, ARDS Trial in Minneapolis (Hydroxychloroquine, Placebo)
Psychological Symptoms in Fibromyalgia Patients Trial (Repitetive transcranial magnetic stimulation)
Not yet recruiting
- Psychological Symptoms in Fibromyalgia Patients
- Repitetive transcranial magnetic stimulation
- (no location specified)
Sep 25, 2022
HIV-HEART Aging Study (15 Year Follow up)
Active, not recruiting
- HIV Infections
- +6 more
-
Essen, Nordrhein-Westfalen, Germany
- +4 more
Jan 9, 2023
Type 1 Diabetes Trial (teplizumab or )
Terminated
- Type 1 Diabetes Mellitus
- teplizumab or placebo
- (no location specified)
Feb 4, 2022
COPD (COPD) Trial in United States (Revefenacin, Placebo, Formoterol)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- Revefenacin
- +2 more
-
Miami, Florida
- +11 more
Feb 22, 2022
Heart Defects, Congenital, Transposition of Great Vessels With Ventricular Inversion Trial in Austria, Switzerland (Tadalafil 20
Completed
- Heart Defects, Congenital
- Transposition of Great Vessels With Ventricular Inversion
- Tadalafil 20 MG
- Placebo 20 MG
-
Wien, Austria
- +6 more
Feb 23, 2022
Parkinson Disease Trial in Luzern (Dexterity training program (HOMEDEXT), Theraband training program)
Completed
- Parkinson Disease
- Dexterity training program (HOMEDEXT)
- Theraband training program
-
Luzern, SwitzerlandLuzerner Kantonsspital
Aug 30, 2016
Resected Stage II or Stage III Colorectal Cancer for Circulating
Recruiting
- Colorectal Cancer Stage II
- Colorectal Cancer Stage III
- Regular blood sample collection for ctDNA assessment
-
California City, California
- +66 more
Jan 6, 2023
Exercise Adherence in Home-based Cardiac Rehabilitation
Not yet recruiting
- Coronary Artery Disease
- survey
-
Beijing, ChinaPeking University Third Hospital
Jul 14, 2021
COPD Trial in Craigieburn, Toronto (Music, Exercise)
Suspended
- Chronic Obstructive Pulmonary Disease
- Music
- Exercise
-
Craigieburn, Victoria, Australia
- +1 more
Apr 29, 2022
Covid19 Trial in Tuebingen (Machine learning, Machine based evaluation)
Unknown status
- Covid19
- Machine learning
- Machine based evaluation
-
Tuebingen, GermanyUniversity Hospital of Tuebingen
Mar 30, 2021
Rheumatic Disease, HIV, AIDS Trial in São Paulo (CoronaVac)
Active, not recruiting
- Rheumatic Disease
- +5 more
- CoronaVac
-
São Paulo, SP, BrazilUniversity of Sao Paulo General Hospital
May 24, 2022
Psoriasis Vulgaris Trial in Surabaya (Lactobacillus Plantarum IS-10506, Placebo)
Recruiting
- Psoriasis Vulgaris
- Lactobacillus Plantarum IS-10506
- Placebo
-
Surabaya, Jawa Timur, IndonesiaUniversitas Airlangga
Feb 15, 2022
Endometriosis Trial in Tanta (laparoscopic examination, Blood sampling)
Completed
- Endometriosis
- laparoscopic examination
- Blood sampling
-
Tanta, El-Gharbyia, EgyptTanta university
Sep 24, 2022
Prostate Cancer Trial in Toronto (focal salvage HDR prostate brachytherapy)
Active, not recruiting
- Prostate Cancer
- focal salvage HDR prostate brachytherapy
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre, Odette Cancer Centre
May 3, 2022
Glioblastoma, Glioblastoma Multiforme, Glioma, Malignant Trial in Jyväskylä, Oulu, New Delhi (EGFRvIII-specific hinge-optimized
Active, not recruiting
- Glioblastoma
- +2 more
- EGFRvIII-specific hinge-optimized CD3 ζ-stimulatory/41BB-co-stimulatory Chimeric Antigen Receptor autologous T-lymphocytes
-
Jyväskylä, Finland
- +2 more
Sep 30, 2021
Neuroblastoma Trial in Pilar, Buenos Aires (Racotumomab)
Active, not recruiting
- Neuroblastoma
-
Pilar, Buenos Aires, Argentina
- +1 more
Sep 30, 2021
Metastatic Leiomyosarcoma Biomarker Protocol
Not yet recruiting
- Leiomyosarcoma
- Plasma Collection
-
Rochester, Minnesota
- +2 more
Jan 5, 2023
COPD (COPD) Trial in Manchester, Nottingham, Southampton (Interferon Beta-1A, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- Interferon Beta-1A
- Placebo
-
Belfast, United Kingdom
- +15 more
Jan 3, 2023
Coronavirus Disease 2019 With Point-of-Care Ultrasonography
Completed
- Coronavirus Infection
- +3 more
- Point-of-Care Ultrasonography (POCUS)
-
Minneapolis, Minnesota
- +1 more
Jan 2, 2023
OCTA Insights in CNVM, Morphological Characteristics and
Not yet recruiting
- Choroidal Neovascularization
- (no location specified)
Sep 14, 2021
End Stage Renal Disease Trial in Düsseldorf, Chieti (XyloCore Low Strenght, XyloCore Medium Strenght, XyloCore High Strenght,
Not yet recruiting
- End Stage Renal Disease
- XyloCore Low Strenght, XyloCore Medium Strenght, XyloCore High Strenght
- 1.36%, 1.5%, 2.27%, 2.5%, 3.86%, 2.25% Glucose PD Solution
-
Düsseldorf, Germany
- +1 more
Mar 28, 2022